ASH, December 3-6, 2016
The ASH Annual Meeting is the world’s premier event in malignant and non-malignant hematology. The meeting will be held in San Diego, CA, USA. Learn more on the ASH website here…
ISHI, December 2-3, 2016
Omixon is attending this year’s Indian Society of Histocompatibility and Immunogenetics conference in Pgimer Chandigarh, India. Visit the ISHI 2016 website here…
Omixon and TBG form Partnership for Asia-Pacific
Omixon and TBG Biotechnology Corp. (TBG), headquartered in Taiwan announce an Exclusive Distribution and Support Partnership for the Asia-Pacific region, including China, Hong Kong, Taiwan and Australia. TBG will be the exclusive distributor of Omixon’s world leading Holotype HLA product for HLA typing by NGS. “With a common goal of driving adoption of...
Join Omixon for our Vendor Presentation at the NGS Workshop in Dallas
We are proud to be one of the Vendors of this year’s ASHI NGS Workshop in Dallas, Texas. Dr. Peter Meintjes, CCO at Omixon will give a Vendor Presentation titled “Omixon: Holotype HLA V2” Date and time: Friday, November 11, 2:00pm-2:30pm CST Venue: Embassy Suites by Hilton Dallas – DFW Airport...
PLOS ONE: Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples
Authors: Yuxin Yin, James H. Lan, David Nguyen, Nicole Valenzuela, Ping Takemura, Yung-Tsi Bolon, Brianna Springer, Katsuyuki Saito, Ying Zheng, Tim Hague, Agnes Pasztor, Gyorgy Horvath, Krisztina Rigo, Elaine F. Reed, Qiuheng Zhang Abstract: Background Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only...
